The overall goal of this program consists of the development and study of combined heart-lung transplantation and single lung transplantation in patients with advanced disease of the heart and/or lungs for whom ordinary forms of treatment offer no realistic hope of effective rehabilitation. Specific scientific objectives include: 1) definition of appropriate criteria for the selection of recipients most likely to benefit from these forms of transplantation; 2) improvement of methods for donor organ procurement and graft preservation (specifically pulmonary); 3) refinement of techniques of intraoperative management; 4) definition of effective postoperative immunosuppressive regimens and evaluation of new methods for the diagnosis of rejection in heart-lung and lung recipients; 5) prospective evaluation and correlative analysis of the pathology and physiology of heart-lung and lung grafts; 6) investigation of pathological and genetic features specific to patients with cystic fibrosis pulmonary disease; and 7) in vitro study of pathophysiological features and pharmacological responses of pulmonary arterial function in the native lungs of patients undergoing cardiopulmonary or isolated pulmonary transplantation. In addition, this multidisciplinary program in clinical heart-lung and lung transplantation provides in-depth training to medical and surgical trainees and constitutes a demonstration project on national and international levels.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL013108-23
Application #
3097471
Study Section
Heart, Lung, and Blood Research Review Committee A (HLBA)
Project Start
1978-05-01
Project End
1993-04-30
Budget Start
1992-05-01
Budget End
1993-04-30
Support Year
23
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Asano, K; Dutcher, D L; Port, J D et al. (1997) Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 95:1193-200
White, M; Wiechmann, R J; Roden, R L et al. (1995) Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation 92:2183-9
Bonnaud, E N; Lewis, N P; Masek, M A et al. (1995) Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant 14:163-71
Girgis, R E; Reichenspurner, H; Robbins, R C et al. (1995) The utility of annual surveillance bronchoscopy in heart-lung transplant recipients. Transplantation 60:1458-61
White, M; Yanowitz, F; Gilbert, E M et al. (1995) Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 76:1271-6
Billingham, M E (1995) Pathology of human cardiac transplantation. Monogr Pathol 37:108-28
Joshi, A; Masek, M A; Brown Jr, B W et al. (1995) ""Quilty"" revisited: a 10-year perspective. Hum Pathol 26:547-57
White, M; Roden, R; Minobe, W et al. (1994) Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 90:1225-38
Kramer, M R; Valantine, H A; Marshall, S E et al. (1994) Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol 73:494-500
Kramer, M R; Stoehr, C; Whang, J L et al. (1993) The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 12:675-81

Showing the most recent 10 out of 147 publications